S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
The gold catalyst we've waited for (Ad)
FuelCell Is Back To Realistic Valuation
Nigeria's central bank chief arrested after being suspended by president
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Boris Johnson's bombshell exit from Parliament leaves UK politics reeling
Can a chatbot preach a good sermon? Hundreds attend church service generated by ChatGPT to find out
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
The gold catalyst we've waited for (Ad)
FuelCell Is Back To Realistic Valuation
Nigeria's central bank chief arrested after being suspended by president
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Boris Johnson's bombshell exit from Parliament leaves UK politics reeling
Can a chatbot preach a good sermon? Hundreds attend church service generated by ChatGPT to find out
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
The gold catalyst we've waited for (Ad)
FuelCell Is Back To Realistic Valuation
Nigeria's central bank chief arrested after being suspended by president
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Boris Johnson's bombshell exit from Parliament leaves UK politics reeling
Can a chatbot preach a good sermon? Hundreds attend church service generated by ChatGPT to find out
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
The gold catalyst we've waited for (Ad)
FuelCell Is Back To Realistic Valuation
Nigeria's central bank chief arrested after being suspended by president
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Boris Johnson's bombshell exit from Parliament leaves UK politics reeling
Can a chatbot preach a good sermon? Hundreds attend church service generated by ChatGPT to find out
NASDAQ:CELC

Celcuity (CELC) Stock Forecast, Price & News

$11.11
+0.17 (+1.55%)
(As of 06/9/2023 ET)
Compare
Today's Range
$10.89
$11.42
50-Day Range
$9.39
$11.31
52-Week Range
$7.42
$14.40
Volume
50,618 shs
Average Volume
44,868 shs
Market Capitalization
$240.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Celcuity MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
12.75% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$6,422 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.69) to ($2.40) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.08 out of 5 stars


CELC stock logo

About Celcuity (NASDAQ:CELC) Stock

Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Receive CELC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celcuity and its competitors with MarketBeat's FREE daily newsletter.

CELC Stock News Headlines

Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Q1 2023 Celcuity Inc Earnings Call
Craig-Hallum Keeps Their Buy Rating on Celcuity (CELC)
Celcuity (CELC) Scheduled to Post Earnings on Monday
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
A Preview Of Celcuity's Earnings
Analyzing Celcuity (NASDAQ:CELC) & Aclarion (NASDAQ:ACON)
Craig-Hallum Remains a Buy on Celcuity (CELC)
Craig-Hallum Initiates a Buy Rating on Celcuity (CELC)
Q4 2022 Celcuity Inc Earnings Call
See More Headlines

CELC Price History

CELC Company Calendar

Last Earnings
3/23/2023
Today
6/10/2023
Next Earnings (Estimated)
8/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CELC
Fax
N/A
Employees
39
Year Founded
N/A

Profitability

Net Income
$-40,370,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$6.17 per share

Miscellaneous

Free Float
16,421,000
Market Cap
$240.98 million
Optionable
Not Optionable
Beta
0.60

Key Executives

  • Brian F. Sullivan
    Chairman & Chief Executive Officer
  • Vicky Hahne
    Chief Financial Officer
  • Lance G. Laing
    Secretary, Director & Chief Science Officer
  • Arthur P. DeCillis
    Chief Medical Officer
  • Sheri Smith
    Head-Clinical Operations













CELC Stock - Frequently Asked Questions

How have CELC shares performed in 2023?

Celcuity's stock was trading at $14.01 at the start of the year. Since then, CELC stock has decreased by 20.7% and is now trading at $11.11.
View the best growth stocks for 2023 here
.

When is Celcuity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our CELC earnings forecast
.

How were Celcuity's earnings last quarter?

Celcuity Inc. (NASDAQ:CELC) posted its quarterly earnings data on Thursday, March, 23rd. The company reported ($0.69) EPS for the quarter, missing the consensus estimate of ($0.54) by $0.15.

What other stocks do shareholders of Celcuity own?
When did Celcuity IPO?

(CELC) raised $18 million in an initial public offering on Wednesday, September 20th 2017. The company issued 2,000,000 shares at $8.00-$10.00 per share. Craig-Hallum Capital Group acted as the underwriter for the IPO.

What is Celcuity's stock symbol?

Celcuity trades on the NASDAQ under the ticker symbol "CELC."

Who are Celcuity's major shareholders?

Celcuity's stock is owned by a variety of retail and institutional investors. Top institutional investors include Commodore Capital LP (6.41%), Geode Capital Management LLC (0.61%), BlackRock Inc. (0.60%), Jacob Asset Management of New York LLC (0.31%), Citigroup Inc. (0.15%) and Renaissance Technologies LLC (0.13%). Insiders that own company stock include Brian F Sullivan, Richard E Buller and Richard Nigon.
View institutional ownership trends
.

How do I buy shares of Celcuity?

Shares of CELC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Celcuity's stock price today?

One share of CELC stock can currently be purchased for approximately $11.11.

How much money does Celcuity make?

Celcuity (NASDAQ:CELC) has a market capitalization of $240.98 million. The company earns $-40,370,000.00 in net income (profit) each year or ($2.66) on an earnings per share basis.

How can I contact Celcuity?

Celcuity's mailing address is 16305 36TH AVENUE NORTH SUITE 100, MINNEAPOLIS MN, 55446. The official website for the company is www.celcuity.com. The company can be reached via phone at (763) 392-0767.

This page (NASDAQ:CELC) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -